Author Question: A patient who has cancer will begin treatment with a colony-stimulating factor. The patient ... (Read 74 times)

jeatrice · **on:** Jul 23, 2018

A patient who has cancer will begin treatment with a colony-stimulating factor. The patient verbalizes understanding of this drug's action with which statement?

a. This drug allows higher doses of chemotherapy.
b. This drug has antitumor activity.
c. This drug has cytotoxic effects.
d. This drug has antiviral effects.

Question 2

A patient is receiving the erythropoietin-stimulating agent epoietin alfa (Procrit). Which assessment finding would cause the nurse to notify the patient's provider?

a. Blood pressure of 90/65 mm Hg
b. Headache and nausea
c. Hemoglobin > 12 g/dL
d. Infiltration of the IV

heinisk01 · **Reply #1 on:** Jul 23, 2018

Answer to Question 1

ANS: A
Colony-stimulating factors permit the delivery of higher doses of drugs because they counter myelosuppression. They do not have antitumor activity, cytotoxic effects, or antiviral effects.

Answer to Question 2

ANS: C
There is an increased risk of death and serious cardiovascular events when the hemoglobin is greater than 12 g/dL. There is no need to notify the provider of the other findings.